Nanoviricides (NNVC) Operating Expenses (2010 - 2026)

Nanoviricides has disclosed Operating Expenses across 17 years of filings, most recently posting $2.0 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 9.73% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $8.2 million (down 17.14% YoY), while the FY2025 annual figure was $9.6 million, up 12.63% from the prior year.
• Operating Expenses came in at $2.0 million for Q1 2026 at Nanoviricides, down from $2.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $3.7 million in Q2 2023 to a low of $1.6 million in Q3 2022.
• Average Operating Expenses over 5 years is $2.2 million, with a median of $2.0 million recorded in 2023.
• Year-over-year, Operating Expenses soared 105.07% in 2023 and plunged 43.28% in 2025.
• Over 5 years, Operating Expenses stood at $1.8 million in 2022, then advanced by 19.13% to $2.2 million in 2023, then fell by 5.75% to $2.1 million in 2024, then grew by 8.46% to $2.2 million in 2025, then retreated by 9.09% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $1.8 million in Q3 2025.